{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:37:49Z","timestamp":1786995469426,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA039335"],"award-info":[{"award-number":["DA039335"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DA038714"],"award-info":[{"award-number":["DA038714"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AR066806"],"award-info":[{"award-number":["AR066806"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM081741"],"award-info":[{"award-number":["GM081741"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["GM103434"],"award-info":[{"award-number":["GM103434"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.pbb.2018.12.009","type":"journal-article","created":{"date-parts":[[2018,12,28]],"date-time":"2018-12-28T11:40:52Z","timestamp":1545997252000},"page":"27-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["CB1 positive allosteric modulation attenuates \u03949-THC withdrawal and NSAID-induced gastric inflammation"],"prefix":"10.1016","volume":"177","author":[{"given":"K.R.","family":"Trexler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.L.","family":"Eckard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.G.","family":"Kinsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.pbb.2018.12.009_bb0005","article-title":"Cannabinoid precipitated withdrawal by the selective cannabinoid receptor antagonist, SR 141716A","volume":"282","author":"Aceto","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2018.12.009_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Health Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.pbb.2018.12.009_bb0015","first-page":"1","article-title":"The current state of pharmacological treatments for cannabis use disorder and withdrawal","author":"Brezing","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2018.12.009_bb0020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(02)02830-3","article-title":"Differential distribution of functional cannabinoid CB1 receptors in the mouse gastroenteric tract","volume":"459","author":"Casu","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2018.12.009_bb0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejphar.2017.05.006","article-title":"MAGL inhibition modulates gastric secretion and motility following NSAID exposure in mice","volume":"807","author":"Crowe","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2018.12.009_bb0030","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.117.245704","article-title":"Monoacylglycerol lipase inhibitors reverse paclitaxel-induced nociceptive behavior and proinflammatory markers in a mouse model of chemotherapy-induced neuropathy","author":"Curry","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2018.12.009_bb0035","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1038\/npp.2010.44","article-title":"FAAH\u2212\/\u2212 mice display differential tolerance, dependence, and cannabinoid receptor adaptation after \u03949-tetrahydrocannabinol and anandamide administration","volume":"35","author":"Falenski","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2018.12.009_bb0040","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s002100000360","article-title":"Cannabinoid CB1-mediated inhibition of stress-induced gastric ulcers in rats","volume":"363","author":"German\u00f2","year":"2001","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pbb.2018.12.009_bb0045","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.npp.1300310","article-title":"Marijuana withdrawal in humans: effects of Oral THC or divalproex","volume":"29","author":"Haney","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2018.12.009_bb0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00213-007-1020-8","article-title":"Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse","volume":"197","author":"Haney","year":"2008","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.pbb.2018.12.009_bb0055","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","article-title":"Prevalence and correlates of DSM-5 cannabis use disorder, 2012\u20132013: findings from the national epidemiologic survey on alcohol and related conditions-III","volume":"173","author":"Hasin","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2018.12.009_bb0060","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1111\/bph.12298","article-title":"In vivo characterization of the highly selective monoacylglycerol lipase inhibitor KML29: Antinociceptive activity without cannabimimetic side effects","volume":"171","author":"Ignatowska-Jankowska","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2018.12.009_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/npp.2015.148","article-title":"A cannabinoid CB1 receptor-positive allosteric modulator reduces neuropathic pain in the mouse with no psychoactive effects","volume":"40","author":"Ignatowska-Jankowska","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2018.12.009_bb0070","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1016\/j.ddtec.2012.07.006","article-title":"Analytical pharmacology and allosterism: the importance of quantifying drug parameters in drug discovery","volume":"10","author":"Kenakin","year":"2013","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.pbb.2018.12.009_bb0075","first-page":"3","article-title":"Modulation of CB1 cannabinoid receptor by allosteric ligands: pharmacology and therapeutic opportunities","volume":"124","author":"Khurana","year":"2016","journal-title":"Neuropeptides"},{"key":"10.1016\/j.pbb.2018.12.009_bb0080","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2013.06.001","article-title":"Acute \u03949-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in mice","volume":"715","author":"Kinsey","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2018.12.009_bb0085","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/jpet.109.155465","article-title":"Blockade of endocannabinoid-degrading enzymes attenuates neuropathic pain","volume":"330","author":"Kinsey","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2018.12.009_bb0090","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1124\/jpet.110.175778","article-title":"Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice","volume":"338","author":"Kinsey","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2018.12.009_bb0095","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1124\/jpet.112.201426","article-title":"Repeated low-dose administration of the monoacylglycerol lipase inhibitor JZL184 retains cannabinoid receptor type 1\u2013mediated antinociceptive and gastroprotective effects","volume":"345","author":"Kinsey","year":"2013","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2018.12.009_bb0100","series-title":"Dronabinol and Lofexidine for Cannabis Use Disorder: A Randomized","first-page":"53","volume":"159","author":"Levin","year":"2016"},{"key":"10.1016\/j.pbb.2018.12.009_bb0105","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0014-2999(98)00558-5","article-title":"Effects of SR 141716A after acute or chronic cannabinoid administration in dogs","volume":"357","author":"Lichtman","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2018.12.009_bb0110","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0091-3057(01)00514-7","article-title":"Precipitated cannabinoid withdrawal is reversed by delta(9)-tetrahydrocannabinol or clonidine","volume":"69","author":"Lichtman","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2018.12.009_bb0115","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nchembio.129","article-title":"Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects","volume":"5","author":"Long","year":"2009","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.pbb.2018.12.009_bb0120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0166-4328(01)00164-4","article-title":"Effects of dopamine antagonists with different receptor blockade profiles on morphine-induced place preference in male mice","volume":"121","author":"Manzanedo","year":"2001","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2018.12.009_bb0125","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2012","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.pbb.2018.12.009_bb0130","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1124\/jpet.108.143487","article-title":"Synergy between enzyme inhibitors of fatty acid amide hydrolase and cyclooxygenase in visceral nociception","volume":"329","author":"Naidu","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2018.12.009_bb0135","doi-asserted-by":"crossref","first-page":"21134","DOI":"10.1073\/pnas.1202906109","article-title":"Anti-inflammatory lipoxin A 4 is an endogenous allosteric enhancer of CB 1 cannabinoid receptor","volume":"109","author":"Pamplona","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2018.12.009_bb0140","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1369\/jhc.2008.950741","article-title":"Cannabinoid CB 1 receptors are expressed by parietal cells of the human gastric mucosa","volume":"56","author":"Pazos","year":"2008","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.pbb.2018.12.009_bb0145","doi-asserted-by":"crossref","first-page":"15184","DOI":"10.1523\/JNEUROSCI.3475-14.2014","article-title":"A lipid gate for the peripheral control of pain","volume":"34","author":"Piomelli","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2018.12.009_bb0150","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.tips.2007.10.006","article-title":"Allosterism and cannabinoid CB1receptors: the shape of things to come","volume":"28","author":"Ross","year":"2007","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2018.12.009_bb0155","first-page":"341","article-title":"ACEA (arachidonyl-2-chloroethylamide), the selective cannabinoid CB 1 receptor agonist, protects against aspirin-induced gastric ulceration","volume":"61","author":"Rutkowska","year":"2006","journal-title":"Pharmazie"},{"key":"10.1016\/j.pbb.2018.12.009_bb0160","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.phrs.2012.02.012","article-title":"Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions","volume":"65","author":"Sasso","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pbb.2018.12.009_bb0165","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1208\/s12248-009-9110-7","article-title":"Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice","volume":"11","author":"Schlosburg","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.pbb.2018.12.009_bb0170","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nn.2616","article-title":"Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system","volume":"13","author":"Schlosburg","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbb.2018.12.009_bb0175","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1124\/jpet.114.212753","article-title":"Prolonged monoacylglycerol lipase blockade causes equivalent cannabinoid receptor type 1 receptor-mediated adaptations in fatty acid amide hydrolase wild-type and knockout mice","volume":"350","author":"Schlosburg","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2018.12.009_bb0180","first-page":"93","article-title":"Analysis of the effect of different neuropeptides in gastric mucosal defense initiated centrally","volume":"60","author":"Shujaa","year":"2009","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.pbb.2018.12.009_bb0185","first-page":"1","article-title":"Positive allosteric modulation of cannabinoid receptor type 1 suppresses pathological pain without producing tolerance or dependence","volume":"011","author":"Slivicki","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2018.12.009_bb0190","doi-asserted-by":"crossref","DOI":"10.1159\/000136851","article-title":"Evaluation of antiulcer activity of tetrahydrocannabinol in the shay rat test","volume":"17","author":"Sofia","year":"1978","journal-title":"Pharmacology"},{"key":"10.1016\/j.pbb.2018.12.009_bb0195","series-title":"Results From the 2015 National Survey on Drug Use and Health: Detailed Tables","volume":"2015","author":"Substance Use and Mental Health Services Administration","year":"2015"},{"key":"10.1016\/j.pbb.2018.12.009_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2018.05.029","article-title":"Novel behavioral assays of spontaneous and precipitated THC withdrawal in mice","author":"Trexler","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2018.12.009_bb0205","first-page":"207","article-title":"Role of sensory nerves in gastroprotective effect of anandamide in rats","volume":"62","author":"Warzecha","year":"2011","journal-title":"J. Physiol. Pharmacol."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718305227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718305227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T04:34:07Z","timestamp":1574829247000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305718305227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":41,"alternative-id":["S0091305718305227"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2018.12.009","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CB1 positive allosteric modulation attenuates \u03949-THC withdrawal and NSAID-induced gastric inflammation","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2018.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}